-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ACU-193 in Mild Cognitive Impairment
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ACU-193 in Mild Cognitive Impairment report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ACU-193 in Mild Cognitive Impairment Drug Details: ACU-193 is under development...
-
Product Insights
NewLikelihood of Approval Analysis for Dementia
Overview How likely is it that the drugs in Dementia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dementia Overview Dementia is the decline in cognitive abilities that impacts a person's...
-
Product Insights
NewLikelihood of Approval Analysis for Gaucher Disease
Overview How likely is it that the drugs in Gaucher Disease will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gaucher Disease Overview Gaucher disease is a rare genetic disorder that occurs...
-
Product Insights
NewLikelihood of Approval Analysis for Hypoglycemia
Overview How likely is it that the drugs in Hypoglycemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypoglycemia Overview Hypoglycemia is a condition characterized by an abnormally low level of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dalzanemdor in Huntington Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dalzanemdor in Huntington Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dalzanemdor in Huntington Disease Drug Details: Dalzanemdor (SAGE-718) is under development...
-
Product Insights
NewLikelihood of Approval Analysis for Developmental Disorders
Overview How likely is it that the drugs in Developmental Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Developmental Disorders Overview Developmental disorders comprise a spectrum of conditions affecting physical,...
-
Product Insights
NewLikelihood of Approval Analysis for Post Partum Depression (Maternal Depression / Postnatal Depression)
Overview How likely is it that the drugs in Post Partum Depression (Maternal Depression / Postnatal Depression) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Post Partum Depression (Maternal Depression /...
-
Product Insights
NewLikelihood of Approval Analysis for Sleep Apnea
Overview How likely is it that the drugs in Sleep Apnea will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sleep Apnea Overview Sleep apnea, a prevalent condition, involves the recurrent interruption...
-
Product Insights
NewLikelihood of Approval Analysis for Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
Overview How likely is it that the drugs in Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)...
-
Product Insights
NewLikelihood of Approval Analysis for Primary Progressive Multiple Sclerosis (PPMS)
Overview How likely is it that the drugs in Primary Progressive Multiple Sclerosis (PPMS) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Primary Progressive Multiple Sclerosis (PPMS) Overview Primary progressive multiple...